Skip to main content
Premium Trial:

Request an Annual Quote

Seegene, DuPont Ink MDx Tech Licensing Deal

NEW YORK (GenomeWeb News) – Seegene and DuPont Nutrition and Health have signed a licensing agreement covering the use of Seegene's multiplex molecular chemistry in DuPont's real-time PCR-based food safety assays.

Under the pact, DuPont will use Seegene's dual-priming oligonucleotide, or DPO, and tagging oligonucleotide capture and extension, or TOCE, technologies in real-time PCR assays for its BAX System for food safety testing.

Financial terms of the agreement were not disclosed.

The companies originally announced in May that they had inked an agreement to jointly develop highly multiplexed assays to detect foodborne pathogens but did not announce a licensing agreement at that time.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.